Yahoo
TSXV - Delayed Quote CAD

Avricore Health Inc. (AVCR.V)

0.0500 0.0000 (0.00%)
At close: October 30 at 10:59:44 AM EDT
Chart Range Bar
Loading chart for AVCR.V
  • Previous Close 0.0500
  • Open 0.0500
  • Bid 0.0450 x --
  • Ask 0.0500 x --
  • Day's Range 0.0500 - 0.0500
  • 52 Week Range 0.0450 - 0.1000
  • Volume 72,312
  • Avg. Volume 37,887
  • Market Cap (intraday) 6.318M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) Dec 1, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

avricore.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AVCR.V
0.00%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

AVCR.V
9.09%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

AVCR.V
71.43%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

AVCR.V
66.67%
S&P/TSX Composite index (^GSPTSE)
69.32%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -50.37%

  • Return on Equity (ttm)

    -132.03%

  • Revenue (ttm)

    193.04k

  • Net Income Avi to Common (ttm)

    -1.8M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    922.55k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -556.63k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: